How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code MZP: Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus. View classification details, related manufacturers, 510(k) clearances, and recall records.
4 clearance records and 11 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Jul 7, 2004 to Nov 3, 2025.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 1 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| MZP · Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus | 4 | 11 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| cobas HCVK252484 · MZP | Roche Molecular Systems, Inc. | 510(k) | Nov 3, 2025FDA decision date |
| Alinity m HCVK252102 · MZP | Abbott Molecular, Inc. | 510(k) | Sep 25, 2025FDA decision date |
| Aptima HCV Quant Dx AssayK233352 · MZP | Hologic, Inc. | 510(k) | Jul 24, 2024FDA decision date |
| Alinity m HCV AMP kit, List (REF) Numbers: a) 08N50-095 and b) 08N50-090. The Alinity m HCV assay is an in vitro reverse transcription-polymeras…Z-0407-2024 · MZP | Abbott Molecular, Inc. | Recall | Nov 29, 2023FDA classification date |
| cobas HCVK221007 · MZP | Roche Molecular Systems, Inc. | 510(k) | Nov 4, 2022FDA decision date |
| The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use.Z-1518-2022 · MZP | Abbott Molecular, Inc. | Recall | Aug 12, 2022FDA record creation date |
| Alinity m System, Part No. 08N53-002Z-0460-2022 · MZP | Abbott Molecular, Inc. | Recall | Jan 6, 2022FDA record creation date |
| Alinity m System, Part No. 08N53-002Z-0461-2022 · MZP | Abbott Molecular, Inc. | Recall | Jan 6, 2022FDA record creation date |
| Alinity m System, Part No. 08N53-002Z-0462-2022 · MZP | Abbott Molecular, Inc. | Recall | Jan 6, 2022FDA record creation date |
| Alinity m System, Part No. 08N53-002Z-0463-2022 · MZP | Abbott Molecular, Inc. | Recall | Jan 6, 2022FDA record creation date |
| COBAS AmpliPrep / COBAS TaqMan HCV Test, US-IVD The COBAS AmpliPrep/COBAS TaqMan HCV Test is an in vitro nucleic acid amplification test for the…Z-2586-2011 · MZP | Roche Molecular Systems, Inc. | Recall | Jun 17, 2011FDA classification date |
| COBAS AmpliPrep / COBAS TaqMan HCV Test, CE-IVD The COBAS AmpliPrep/COBAS TaqMan HCV Test is an in vitro nucleic acid amplification test for the…Z-2587-2011 · MZP | Roche Molecular Systems, Inc. | Recall | Jun 17, 2011FDA classification date |
| Amplilink Software Versions 1.1, 1.3, 1.4, 2.41 COBAS AmpliPrep/COBAS Amplicor HCV Test, version 2.0Z-1107-2007 · MZP | Roche Molecular Systems, Inc. | Recall | Aug 2, 2007FDA classification date |
| Amplicor [3] AV-HRP. (Avidin-HRP (Horseradish Peroxidase) BGG Conjugate.) Kit: Amplicor HCV Detection Kit, v2.0Z-1362-04 · MZP | Roche Molecular Systems Inc | Recall | Aug 19, 2004FDA classification date |
| Amplicor [3] AV-HRP, Avidin-HRP (Horseradish Peroxidase) BGG Conjugate. Kit: AmpliCap HCV MonitorTest, Export, RUO.Z-1364-04 · MZP | Roche Molecular Systems Inc | Recall | Aug 19, 2004FDA classification date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.